These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1825627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR, Rutkowski AF.
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [Abstract] [Full Text] [Related]

  • 3. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM, Kelly KJ, Gilliland SS, Kohls PK, Nahum A, Vance-Bryan K.
    Pharmacotherapy; 1993 Aug; 13(6):647-55. PubMed ID: 7905621
    [Abstract] [Full Text] [Related]

  • 4. Drug-induced paralysis (muscle relaxant) therapy in the mechanically ventilated neonate.
    Moss JE, Purohit DM.
    J Perinatol; 1988 Aug; 8(4):321-4. PubMed ID: 2976816
    [Abstract] [Full Text] [Related]

  • 5. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H, Jeng J, Tilly E, St Andre A, Champion H.
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Muscle weakness in mechanically ventilated patients with severe asthma.
    Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C.
    Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
    [Abstract] [Full Text] [Related]

  • 8. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ, Hoey LL, Vance-Bryan K.
    Pharmacotherapy; 1996 May; 16(5):899-904. PubMed ID: 8888085
    [Abstract] [Full Text] [Related]

  • 9. [Paralysis after long-term administration of neuromuscular blocking agents].
    Sugai N.
    Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497
    [Abstract] [Full Text] [Related]

  • 10. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J, Rashkovsky OM, Ket JM, Koot HW, Hermans J, Agoston S.
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN, Singletary TJ.
    Pharmacotherapy; 1997 Dec; 17(6):1322-7. PubMed ID: 9399619
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New muscle relaxants in outpatient anesthesiology.
    Goldberg M, Rosenberg H.
    Dent Clin North Am; 1987 Jan; 31(1):117-29. PubMed ID: 3542610
    [Abstract] [Full Text] [Related]

  • 18. [Neuromuscular blockade. Dosage of nondepolarizing agents to risk-group patients].
    Holst PE, Ostergaard D, Bonde J.
    Ugeskr Laeger; 1995 Feb 20; 157(8):1051-5. PubMed ID: 7879309
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AAEM case report #29: Prolonged paralysis after neuromuscular blockade.
    Gooch JL.
    Muscle Nerve; 1995 Sep 20; 18(9):937-42. PubMed ID: 7643872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.